Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipientss⃞

Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipientss⃞

The Assessment of Lescol in Renal Transplantation clinical trial demonstrated the efficacy of fluvastatin in reducing cardiovascular (CV) disease in renal transplant recipients. The study included a voluntary pharmacogenetic component, enrolling 1,404 patients, which allowed association testing of b...

Full description

Bibliographic Details
Main Authors: Jonathan B. Singer, Hallvard Holdaas, Alan G. Jardine, Bengt Fellstrøm, Ingrid Os, Georgina Bermann, Joanne M. Meyer
Format: Article
Language:English
Published: Elsevier 2007-09-01
Series:Journal of Lipid Research
Subjects:
pharmacogenetics
association
cholesteryl ester transfer protein
3-hydroxy-3-methylglutaryl-coenzyme A reductase
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520424952

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520424952

Similar Items